Treatment of Metastatic Melanoma

Surgery continues to be the mainstay treatment for melanoma localized to the primary tumor and/or lymph nodes. Results from randomized controlled trials indicate that sentinel node biopsy for the treatment of cutaneous melanoma of intermediate thickness has a beneficial effect on recurrence rates, a...

Full description

Saved in:
Bibliographic Details
Other Authors: Morton, Rachael (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2011
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_65193
005 20210420
003 oapen
006 m o d
007 cr|mn|---annan
008 20210420s2011 xx |||||o ||| 0|eng d
020 |a 1034 
020 |a 9789533075747 
020 |a 9789535165132 
040 |a oapen  |c oapen 
024 7 |a 10.5772/1034  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Morton, Rachael  |4 edt 
700 1 |a Morton, Rachael  |4 oth 
245 1 0 |a Treatment of Metastatic Melanoma 
260 |b IntechOpen  |c 2011 
300 |a 1 electronic resource (362 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Surgery continues to be the mainstay treatment for melanoma localized to the primary tumor and/or lymph nodes. Results from randomized controlled trials indicate that sentinel node biopsy for the treatment of cutaneous melanoma of intermediate thickness has a beneficial effect on recurrence rates, and adjuvant radiotherapy to regional lymph node fields following surgical resection reduces loco-regional recurrence in patients at high risk of relapse. Isolated limb perfusion, electrochemotherapy, and photodynamic therapy continue to be evaluated for treatment of stage IV disease. However, the greatest excitement in new treatment has been with targeted therapies for genetic mutations. In particular, the promising results of partial and complete tumor response in stage IV disease from early phase trials of the B-RAF kinase inhibitors. This book provides a contemporary insight into the therapeutic treatment options for patients with metastatic melanoma and is relevant to clinicians and researchers worldwide. In addition, an update on current clinical trials for melanoma treatment has been included, and two chapters have been reserved to discuss the treatment of oral and uveal melanoma. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a Oncology 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/523/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/65193  |7 0  |z DOAB: description of the publication